| Literature DB >> 27163657 |
Garden Tabacchi1, Claudio Costantino1, Giuseppe Napoli1, Valentina Marchese1, Manuela Cracchiolo1, Alessandra Casuccio1, Francesco Vitale1.
Abstract
Low measles, mumps and rubella (MMR) immunization levels in European children highlight the importance of identifying determinants of parental vaccine uptake to implement policies for increasing vaccine compliance. The aim of this paper is to identify the main factors associated with partial and full MMR vaccination uptake in European parents, and combine the different studies to obtain overall quantitative measures. This activity is included within the ESCULAPIO project, funded by the Italian Ministry of Health. ORs and CIs were extracted, sources of heterogeneity explored and publication bias assessed. Forty-five papers were retrieved for the qualitative study, 26 of which were included in the meta-analysis. The following factors were associated with lower MMR vaccine uptake: misleading knowledge, beliefs and perceptions on vaccines (OR 0.57, CI 0.37-0.87); negative attitudes and behaviors toward vaccination (OR 0.71, CI 0.52-0.98); demographic characteristics, such as different ethnicity in Southern populations (OR 0.44, CI 0.31-0.61), higher child's age (OR 0.80, CI 0.76-0.85); low socio-economic status (OR 0.64, CI 0.51-0.80), especially low income (OR 0.39, CI 0.25-0.60) and education (OR 0.64, CI 0.48-0.84), high number of children (OR 0.54, CI 0.42-0.69), irregular marital status (OR 0.80, CI 0.66-0.96). The factors explaining heterogeneity were country location, administration modality, collection setting and responses reported on MMR alone or in combination. Findings from this study suggest policy makers to focus communication strategies on providing better knowledge, correct beliefs and perceptions on vaccines, and improving attitudes and behaviors in parents; and to target policies to people of ethnic minority from Southern Europe, low educated and deprived, with higher number of children and non-married marital status.Entities:
Keywords: determinant; measles; mumps and rubella; parents; uptake; vaccine
Mesh:
Substances:
Year: 2016 PMID: 27163657 PMCID: PMC4964810 DOI: 10.1080/21645515.2016.1151990
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452
Figure 1.Flow diagram of the systematic literature review process on the determinants of European parents' decision of vaccinating their children against measles, mumps and rubella.
Studies selected through the systematic review of the underlying determinants of European parents' decision on vaccinating their children against measles, mumps and rubella (MMR).
| Ref. Article | Publication year | Study year | Country | Sample size | Children's age | Data collection method | Administration modality | Administration setting | Vaccine | MMR specific yes/no | Vaccine schedule adherence | Qualitative / Quantitative study | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lernout T | 2014 | 2012 | Belgium | 874 | 18–24 mo | questionnaire | IW | home (face-to-face) | MMR and DTP | yes | partial | quantitative (included in the meta-analysis) |
| 2 | Robert E | 2014 | 2012 | Belgium | 519 (in Wallonia); 538 (in Brussels) | 18–24 mo | interview | IW | home (face-to-face) | MMR in a schedule | no | partial | quantitative (included in the meta-analysis) |
| 3 | Harmsen IA | 2013 | 2011 | The Netherlands | 60 | 0–4 y | focus groups: semistructured protocol with open-ended questions. Digital voice recorded and transcribed verbatim | IW | antroposophical child welfare centers | MMR in a schedule | no | NS | qualitative |
| 4 | Pavlopoulou ID | 2013 | 2010–2011 | Greece | 731 | 0–65 mo | interview | IW | home (telephone) | MMR in a schedule | no | full and partial | quantitative (included in the meta-analysis) |
| 5 | Pearce A | 2013 | 2003–2007 | UK | 751 | 5 y | interview | IW | home (face-to-face) | MMR | yes | full and partial | quantitative (included in the meta-analysis) |
| 6 | van Lier A | 2013 | 2009 | The Netherlands | 180,456 | 0–14 mo | Country of birth were taken from Præventis (2 October 2009); proxy for SES from The Netherlands Institute for Social Research; proxy of religious objection to vaccination from municipal offices. | NA | official records | MMR in a schedule | yes | full | quantitative (included in the meta-analysis) |
| 7 | Bouhamam N | 2012 | 2009–2010 | France | 375 | 9 mo - 7 y | questionnaire | IW | hospital (face-to-face) | MMR in a schedule | yes | full | quantitative (included in the meta-analysis) |
| 8 | Brown K | 2012 | 2008/2009 | UK | 24 | 11 mo-3.5 y | interview | IW | home (face-to-face and telephone) | MMR | yes | full and partial | qualitative |
| 9 | Kriwy P | 2012 | 2001 | Germany | 464 | NS | interview | IW | home (face-to-face) | MMR | yes | full | quantitative |
| 10 | Mollema L | 2012 | 2006–2007 | The Netherlands | 1,744 | 0–10 y | questionnaire | SA | home | MMR in a schedule | no | partial | quantitative (included in the meta-analysis) |
| 11 | Schönberger K | 2012 | 2002–2005 | Germany | 1,774 | < 4 y | interview | IW | home (telephone) | MMR | yes | full and partial | quantitative (included in the meta-analysis) |
| 12 | Brown K | 2011 | 2008–2010 | UK | 284 | 5–18 y | questionnaire | SA | home (postal) | MMR | yes | full | quantitative (included in the meta-analysis) |
| 13 | Brown K | 2011 | 2009 | UK | 373 | 5–18 y | questionnaire | SA | home (postal) | MMR | yes | full and partial | quantitative (included in the meta-analysis) |
| 14 | Coniglio MA | 2011 | 2008 | Italy | 1,218 | 3–5 y | questionnaire | SA | day-care center | MMR in a schedule | no | NS | quantitative |
| 15 | Sakou I-I | 2011 | 2009 | Greece | 1,005 | 14 y | questionnaire | IW | hospital (face-to-face) | MMR in a schedule | no | full | quantitative (included in the meta-analysis) |
| 16 | Babatsikou F | 2010 | NS | Greece | 304 | 0–12 y | questionnaire | SA | day-care centers and primary schools | MMR in a schedule | no | NS | quantitative |
| 17 | Danis K | 2010 | 2006 | Greece | 2,950 | 6 y | questionnaire | SA | school | MMR in a schedule | no | full | quantitative (included in the meta-analysis) |
| 18 | Gardner B | 2010 | 2008 | UK | 28 | < 6 y | Focus group discussions informed by a booklet and transcribed verbatim | NA | primary care trust | MMR | yes | NA | qualitative |
| 19 | Jessop LJ | 2010 | 2001–2004 | Ireland | 556 | 5 y | questionnaire | SA | hospital | MMR | yes | partial | quantitative (included in the meta-analysis) |
| 20 | Borràs E | 2009 | 2003–2004 | Spain | 630 | < 3 y | questionnaire | IW | home (telephone) | MMR in a schedule | no | partial | quantitative (included in the meta-analysis) |
| 21 | Borràs E | 2009 | 2003–2005 | Spain | 630 | < 3 y | questionnaire | IW | home (telephone) | MMR in a schedule | no | partial | quantitative (included in the meta-analysis) |
| 22 | Pearce A | 2008 | 2000–2002 | UK | 13,826 | 9 mo - 3 y | interview | IW | home (face-to-face) | MMR | yes | full and partial | quantitative (included in the meta-analysis) |
| 23 | Theeten H | 2009 | 2005 | Belgium | 792 | 7 y | questionnaire | IW | home (face-to-face) | MMR in a schedule | yes | full | quantitative (included in the meta-analysis) |
| 24 | Vandermeulen C | 2008 | 2005 | Belgium | 3,490 | <18 y | questionnaire | IW | home (face-to-face) | MMR | yes | full | qualitative |
| 25 | Mixer RE | 2007 | 2003 | UK | 6,444 quantitative study; 37 qualitative study | 18 mo - 3 y | For quantitative study: ethnicity data from Brent Primary Care Trust database. For qualitative study: focus groups and interviews transcribed verbatim. A questionnaire on socioeconomic status was filled in | For ethnicity: records. For qualitative study: IW | primary care trust (face-to-face and records) | MMR | yes | partial | quantitative (included in the meta-analysis) and qualitative |
| 26 | Smith A | 2007 | 1996–2006 | UK | 1,004 | < 36 mo | interview | IW | home (face-to-face) | MMR | yes | NA | qualitative |
| 27 | Theeten H | 2007 | 2005 | Belgium | 1,349 | 18–24 mo | interview and questionnaire | IW | home (face-to-face) | MMR in a schedule | yes | partial | quantitative (included in the meta-analysis) |
| 28 | Casiday R | 2006 | 2004 | UK | 87 | < 4 y | questionnaire | SA | home (postal) | MMR | yes | NS | quantitative |
| 29 | Cassell JA | 2006 | 2004 | UK | 413 | 15–24 mo | questionnaire | SA | home (postal) | MMR | yes | full | quantitative (included in the meta-analysis) |
| 30 | Paulussen TG | 2006 | 1999 | The Netherlands | 491 | 0–4 y and 9–10 y | questionnaire (computer-based) | SA | home | MMR in a schedule | no | full | quantitative (included in the meta-analysis) |
| 31 | Wright J | 2006 | 1993–2004 | UK | 303 | < 2 y | official records | NA | NA | MMR | yes | NS | quantitative |
| 32 | Dannetun E | 2005 | 2003 | Sweden | 203 | < 4 y | questionnaire | SA | home (telephone) | MMR | yes | NS | qualitative |
| 33 | Gellatly J | 2005 | 2003–2004 | UK | 105 | 1–56 mo | questionnaire | IW | nursery (face-to-face) | MMR | yes | full | quantitative (included in the meta-analysis) |
| 34 | Hak E | 2005 | 1999 | The Netherlands | 150 | 3 mo - 5 y | focus group interview and questionnaire | SA | day-care center | MMR in a schedule | no | full | quantitative (included in the meta-analysis) |
| 35 | Alfredsson R | 2004 | 1999 | Sweden | 250 | < 4 y | questionnaire | SA | home (postal) | MMR | yes | NS | qualitative |
| 36 | Flynn M | 2004 | 1997–1998 | UK | 511 | 2 y | questionnaire | SA | home (postal) | MMR | yes | NS | quantitative (included in the meta-analysis) |
| 37 | McMurray R | 2004 | 2002–2003 | UK | 69 | 4–5 y | interview | IW | home (face-to-face) | MMR | yes | NS | qualitative |
| 38 | Petrovic M | 2003 | 1997 | UK | NA | NA | questionnaire | SA | home (postal) | MMR | yes | full | quantitative (included in the meta-analysis) |
| 39 | Smailbegovic MS | 2003 | 2000–2001 | UK | 76 | 0–18 mo | questionnaire | SA | home | MMR in a schedule | yes | NS | qualitative |
| 40 | Alonso JAN | 2002 | 2000 | Spain | NS | NS | questionnaire | SA | home (postal) | MMR in a schedule | no | NS | qualitative |
| 41 | Ramsay ME | 2002 | 2001 | UK | 1,013 | <3 y | interview | IW | home (face-to-face) | MMR | yes | NS | qualitative |
| 42 | Evans M | 2001 | NS | UK | 48 | 14 mo-3 y | focus groups with interviews | NA | community hall | MMR | yes | NS | qualitative |
| 43 | Swennen B | 2001 | 1999 | Belgium | 1,005 (Flanders), 835 (Wallonia) | 18–24 mo | interview | IW | NS | MMR in a schedule | no | NS | qualitative |
| 44 | Impicciatore P | 2000 | 1997 | Italy | 1,035 | <6 y | questionnaire | IW | shopping centers and parks (face-to-face) | MMR | yes | full | quantitative (included in the meta-analysis) |
| 45 | Pareek M | 2000 | NS | UK | 300 | <36 mo | questionnaire | SA | home (postal) | MMR | yes | full | quantitative |
4 doses hexavalent, 3 doses pneumococcal, 1 dose MMR,1 dose MenC.
MMR, DTP/DTaP, OPV/IPV, Hib, HBV
MMR, DTaP-IPV, Hib, Men C
polio, DTP, MMR, Hib, MenC, HBV, HPV
2 doses MMR, diphtheria, tetanus, poliomyelitis, Hib, pertussis, tuberculosis, pneumococcal, HBV
polio, DTP, MMR, Hib, MenC, HBV, pneumococcal, HPV
IPV, DT, HBV, MMR, pertussis, varicella, pneumococcal, Hib
The adolescent booster dose (6th dose) Td or Tdap, 5 or more doses polio, 3 or more doses HBV, 2 doses HAV, 2 doses MMR, 1 dose MenC
5 doses DTP, 5 doses polio, 2 doses MMR, 3 doses HBV; MMR available at that time, if they had received 1 dose, at the age of >12 months, and the booster at the age> 10 y; 4 doses Hib if the first dose was administered at the age of 0–6 months and the 4th at the age of > 12 months; alternatively for Hib, 3 doses if vaccination began at the age of 7–11 months and the 3rd dose was administered at the age of > 12 months, or 2 doses if the first dose was administered at the age of 12–14 months or 1 dose if Hib vaccination was administered at the age of > 15 months.
5 doses DTP, 5 doses polio, 2 doses MMR, 3 doses HBV, full vaccination for Hib
4 DTPa/w doses, 4 Hib doses, 4 OPV doses, 3 MenC doses and 1 MMR dose
4 DTP, 4 OPV, 1 MMR, and the necessary doses of Hib and MenC
OPV, DTP, HBV, MMR, MenC and booster DT-IPV
4 doses IPV, DTP and Hib, 3 doses HBV and 1 dose MMR and MenC
4 injections of a combined vaccine for diphtheria, tetanus, pertussis and poliomyelitis (DPeTPo), 2 injections with a combined vaccine for diphtheria, tetanus and poliomyelitis (DT-Po), 4 injections with a conjugated vaccine for Hib, 2 injections with a combined MMR vaccine (MuMeR).
DPTP, Hib, MMR, MenC, diphtheria, tetanus and polio, a-cellular pertussis
BCG, pertussis, polio, Hib, MenC, MMR
DTP, OPV, Hib, MMR
polio, DTP, Hib, HBV, MMR
Abbreviations
DTP:diphtheria-tetanus-pertussis; DTaP or Tdap: diphtheria-tetanus-acellular pertussis; DT or Td: diphtheriatetanus
MenC: Meningococcus C
OPV/IPV: Oral polio vaccine/Inactivated polio vaccine
Hib: Haemophilus influenzae type b
HBV: hepatitis B
HPV: human papillomavirus
HAV: hepatitis A
BCG: Bacillus Calmette-Guerin
Characteristics of the retrieved 45 articles on the determinants of European parental decision of vaccinating their children against measles, mumps and rubella (MMR).
| Study characteristics | No. | % |
|---|---|---|
| Data collection method | ||
| • Questionnaires | 28 | 62 |
| • Interviews | 12 | 27 |
| • Focus groups | 5 | 11 |
| • Official records | 3 | 7 |
| Administration modality | ||
| • Interviewer-administered | 23 | 51 |
| • Self-administered | 18 | 40 |
| Data collection setting | ||
| • Home | 29 | 64 |
| • Hospital/nursery/primary care trust | 6 | 13 |
| • Day-care centers/Schools | 4 | 9 |
| • Other | 3 | 7 |
| Geographical location | ||
| • Northern Europe | 22 | 49 |
| • Western Europe | 14 | 31 |
| • Southern Europe | 9 | 20 |
| Questionnaires reporting on | ||
| • MMR vaccine alone | 31 | 69 |
| • MMR plus other vaccines included in the local schedule | 14 | 31 |
| MMR vaccine schedule adherence | ||
| • All recommended doses | 15 | 33 |
| • 1 dose | 8 | 18 |
| • Both | 6 | 13 |
| Children's age at the moment of the study | ||
| • ≤ 5 y | 30 | 67 |
| • > 5 y | 3 | 7 |
| • Mixed age | 9 | 20 |
using semi-structured protocol with open-ended questions, questionnaires or interviews, or discussions, recorded and transcribed
delivered by post, by telephone or by hand, or face-to-face interviews
anthroposophical child welfare centers, community halls, shopping centers and parks
19 studies in UK, 2 in Sweden, 1 in Ireland
6 studies in Belgium, 5 in The Netherlands, 2 in Germany, 1 in France
4 studies in Greece, 3 in Spain, 2 in Italy
Figure 2.Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella, reported in the retrieved 45 articles.
Figure 3.Forest plot of the overall effect (showed as exponentiated Odds Ratios and Confidence Intervals) of parental knowledge, beliefs and perceptions (KBP) on measles, mumps and rubella vaccine uptake, examined by KBP on vaccines and on diseases.
Figure 4.Forest plot of the overall effect (showed as exponentiated Odds Ratios and Confidence Intervals) of parental ethnic minority on measles, mumps and rubella vaccine uptake, examined by study geographical location.
Figure 5.Forest plot of the overall effect (showed as exponentiated Odds Ratios and Confidence Intervals) of parental socio-economic status on measles, mumps and rubella vaccine uptake, examined by specific socio-economic determinants.
Figure 6.Forest plot of the overall effect (showed as exponentiated Odds Ratios and Confidence Intervals) of parental information source/advice opinions on measles, mumps and rubella vaccine uptake, examined by administration modality.
Analysis for funnel plot asymmetry of studies reporting the different variables, estimated by Egger's regression test.
| No. studies | coefficient | 90% CI | p-value | |
|---|---|---|---|---|
| Knowledge, beliefs, perceptions (right | 19 | −2.21 | −5.560 – 1.178 | 0.272 |
| Attitudes/behaviors (positive | 18 | −0.83 | −3.508 – 1.843 | 0.595 |
| Ethnicity (different | 31 | 3.24 | 0.339 – 6.138 | |
| Socio-economic status (high | 24 | 2.55 | 0.825 – 4.268 | |
| Information source/advice (sufficient | 11 | 6.64 | 2.140 – 11.137 |